MedTrace Logo

User Surveillance in Ulcerative Colitis

NCT01363453 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2011-06-01

No results posted yet for this study

Summary

The aim of the non-interventional study is to document the daily doses in acute and remission therapy, the frequence of doses (1, 2, 3 or 4 times daily), when rectal dosage forms are added and, when and how long steroids are given.

Conditions

Sponsors & Collaborators

  • Ferring Arzneimittel GmbH

    collaborator INDUSTRY

  • Ferring Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Clinical Development Support · Ferring Pharmaceuticals

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2008-05-31
Completion
2008-07-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01363453 on ClinicalTrials.gov